ABSTRACT
INTRODUCTION
In the central nervous system (CNS), neuronal generation in the postnatal and adult brain is restricted to highly localized germinal niches, most notably the subventricular zone (SVZ) located in the forebrain lateral ventricle (LV). Neural stem cells (NSCs) of the postnatal and adult SVZ primarily give rise to olfactory neurons and oligodendrocytes (OLs), the myelinating cells of the CNS [1] [2] [3] . SVZ-NSCs (also referred as type-B cells) give rise to actively proliferating transiently amplifying cells, named type-C cells that either differentiate into neuronal precursors (NPs, type-A cells) or oligodendrocyte precursor cells (OPs) [4] . NPs migrate along the rostral migratory stream to the olfactory bulb, where they differentiate into phenotypically distinct populations of interneurons [2, 5] , while OPs migrate throughout the forebrain to differentiate into myelinating OLs [6] . Recent studies indicate that the neurogenic fate of SVZ-NSCs depends on their location within microdomains of the SVZ [7] [8] [9] [10] [11] , whereby NSCs in the dorsal SVZ (dSVZ) give rise to OPs and glutamatergic neurons of the olfactory bulb [6, 12, 13] , and NSCs located in both the dorsal and lateral SVZ (lSVZ) generate distinct subtypes of GABAergic interneurons [5, 14] . Moreover, transcription factors that are involved in the early specification of SVZ-NSCs toward the different lineages are expressed in defined SVZ microdomains [9, 12, 14] . For example, the NP transcription factor Tbr2 (also referred to as Eomes) that regulates differentiation of glutamatergic neurons is largely restricted to the dSVZ, together with the OL lineage transcription factor Olig2 [13, 15] . In contrast, the NP transcription factor Dlx2 that regulates the differentiation of GABAergic neurons is enriched in a Brain Research Institute, University of Z€ urich/ETHZ, Z€ urich, Switzerland; the lSVZ [14] . Although it was thought that heterogeneity of SVZ-NSC fates is intrinsically coded, a recent study identified Shh as a ventralizing factor in the adult SVZ, where Shh was able to respecify dSVZ-NSCs to acquire ventral neuronal fates [16] . In contrast, the factors that maintain SVZ-NSC dorsalization postnatally are unresolved, but canonical Wnt/b-catenin signaling has been identified as an important dorsalizing factor during embryonic (E9.5) cortical development [17] . Furthermore, a role for Wnt/bcatenin has been described in the adult SVZ, where it controls proliferation of NSCs and NPs [18] , although another study suggested Wnt signaling has opposing roles in the developing and the adult brain, being more important in NSC differentiation in the latter, rather than proliferation [19] . Similarly, studies in which Wnt/b-catenin signaling was constitutively activated in OL lineage cells indicated that this signaling pathway regulates postnatal OL differentiation, but not proliferation [20] . In contrast, we found that stimulation of Wnt/b-catenin signaling with the Wnt mimetic AR-A014418 increased both proliferation and differentiation of OL lineage cells in vivo in the postnatal forebrain [21] . This is consistent with a recent study in the adult indicating a specific role for canonical Wnt signaling in selectively stimulating proliferation within the OL lineage, without changing lineage choice or proliferation within neurogenic clones [22] .
Hence, there is increasing evidence that Wnt/b-catenin signaling in the SVZ persists after birth, but its potential role in regulating fate specification of NSCs within SVZ microdomains has not been investigated so far. Here, we show that canonical Wnt/b-catenin signaling is primarily active in the dSVZ of the postnatal forebrain and selectively regulates the fate of dSVZ-NSCs into OPs and glutamatergic NPs.
MATERIALS AND METHODS
Unless otherwise stated, materials were obtained from SigmaAldrich (Buchs, Switzerland, www.sigmaaldrich.com). All experiments on animals were performed in agreement with the Canton of Zurich veterinary office guidelines. All transgenic mice were maintained in a BL/6 background. For in vivo experiments, pups were anesthetized by hypothermia.
SVZ Microdissection
SVZ microdomains were microdissected using previously published protocols [15] . In brief, mice aged postnatal day 6 (P6) were killed humanely by cervical dislocation and brains were rapidly dissected and placed in ice-cold postnatal-specific coronal brain matrix (Zivic Instruments, Pittsburgh, PA, www.zivicinstruments.com). Tissue segments of 500 lm thickness containing the rostral LV were isolated and the lSVZ and dSVZ were microdissected for subsequent analysis by real-time quantitative polymerase chain reaction (rt-qPCR) or Western blot. One litter was used to pool sufficient quantities of microdissected tissue for subsequent Western blot or RNA extraction for 1 "n" value.
RNA Extraction, Amplification, and rt-qPCR
Maintaining strict RNase-free and sterile conditions throughout, RNA was amplified using 3 ng as input material for all samples with the Nugene Pico Oviation WT kit (NuGEN Technologies, Inc., San Carlos, CA, www.nugeninc.com) following manufacturer's guidelines. Synthesized cDNA was purified using Qiagen MinElute reaction clean up kit (Qiagen, Valencia, CA, www.qiagen.com). For rt-qPCR, amplified cDNA was loaded with 5 lM of forward and reverse primers, SYBR green mastermix, and DNAase/RNase-free H 2 O onto 96-well plates for Lightcycler 480 (Roche Diagnostics, Rotkreuz, Switzerland, www.roche-diagnostics.com). Relative gene expression was determined using the DD 2ct method versus the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). See Supporting Information Table S1 for list of primers and their source. Gene expression data are presented as mean 6 standard error of the mean (SEM), and samples compared for significance using unpaired t test (t test) in Prism v3.02 software; (GraphPad, La Jolla, CA, www.graphpad.com).
Pharmacological Stimulation of Wnt/b-Catenin
As previously described, the Wnt/b-catenin pathway was activated pharmacologically by intraventricular infusion of the glycogen synthase kinase 3b (GSK3b) inhibitor AR-A014418 into the LV to achieve a concentration of 6 lM/l in the ventricular cerebrospinal fluid (CSF), which we have shown effectively inhibits GSK3b in periventricular regions, as determined by phosphorylation of Ser9-GSK3b [21] . Sterile saline/DMSO vehicle was used as a control.
Western Blot
AR-A014418 was infused into the LV of both hemispheres at P6, and animals were sacrificed 45 minutes after the final AR-A014418 infusion. Microdissected SVZ microdomains were snap frozen, briefly centrifuged at 4,000g to obtain tissue pellets, and protein extracted with ice-cold lysis buffer containing protease inhibitors. Lysed tissue supernatant was transferred to Ultrafree MC centrifugal spin columns (Millipore, Zug, Switzerland, www.millipore.com) for separation and concentration of protein extracts above 15 kDa. Cytoplasmic and nuclear extracts were obtained using the "NE-PER Nuclear and Cytoplasmic Extraction" kit (Thermo Fisher Scientific, Waltham, MA, www.thermofisher.com) and protein concentration determined by Bradford protein assay. Standard procedures were followed. See Supporting Information Table S2 for a list of primary antibodies and species-matched secondary HRPconjugated secondary antibodies, all used at 1:1,000 (Dako; Baar, Switzerland, www.dako.com). Protein bands were detected by adding SuperSignal West Pico Chemiluminescent Substrate (Pierce, Waltham, MA, www.thermofisher.com) and by exposing the blot in a Stella detector (Raytest, Straubenhardt, Germany, www.raytest.com). Densitometry analysis was performed with NIH software by normalizing the band intensities to total GSK3b or, in the case of b-catenin, to b-actin or Lamin B1.
Transgenic Mouse Lines
For analysis of canonical Wnt/b-catenin signaling, we used the b-catenin-activated transgene reporter transgenic mouse line (also referred to as Bat-Gal mice), in which the lacZ gene is under the control of seven consensus Lef1/Tcf-binding motifs driving the expression of the b-Galactosidase reporter, termed "bGal" [23] . 
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contains a phosphorylation site that targets b-catenin to degradation; and in this mouse line, the floxed exon3 is removed upon Cre-mediated recombination, resulting in a constitutive stabilized form of b-catenin [24] . For loss-of-function experiments, the b-catenin floxed mouse line (b-catenin lox/lox ) was used (Jax mouse stock: 004152, Bar Harbor, ME, www.jaxmice. jax.org), in which loxP sites are inserted in intron 1 and intron 6, so that recombination induces deletion of exons 2-6, resulting in ablation of b-catenin [25] . In addition, we used the signaling mutant line b-catenin dm/lox , in which endogenous bcatenin protein is replaced by a mutant form that maintains the cell adhesion functions of b-catenin, but upon Cremediated recombination, its Lef1/Tcf-binding domains are removed, thus preventing the activation of canonical Wnt/ b-catenin nuclear targets [26] . Mice were genotyped as previous [26] .
Plasmid Preparation and Postnatal Electroporation
A pCAGs-Cre:GFP plasmid and control plasmid pCAGs-green fluorescent protein (GFP) under a chicken b-actin promoter were obtained from Addgene (Cambridge, MA, www.addgene. org, plasmids 13775; 11150). Control plasmid lacked the Crerecombinase coding sequence (pCAGs-GFP). Plasmids were amplified and purified using the Qiagen EndoFree Plasmid Maxi Kit following manufacturer's guidelines (Qiagen, Valencia, CA, www.qiagen.com). The bGal plasmid used to identify active Wnt signaling in transfected cells codes for a nuclear bGalactosidase reporter, was obtained from Addgene (20889) and is the same construct as the Bat-Gal reporter mouse strain described above [23] . Electroporation of NSCs in direct contact with the ventricular surface was performed as previously described [8] . Mice aged P2 were electroporated and analyzed 4 days later. In the case of pharmacological stimulation of Wnt/b-catenin, CD1 mice were electroporated at P3 and were then infused with AR-A014418 at P4 and P5, prior to analysis at P6.
Enhancement or ablation of b-catenin transcriptional activity in the b-catenin exon3 and b-catenin lox/lox mice (see above) was confirmed by coelectroporating the bGal reporter plasmid with the GFP:Cre fusion plasmid [23] . Cre-mediated recombination successfully enhanced or reduced transfected cells bGal nuclear expression in the b-catenin exon3 or b-catenin lox/lox mice, respectively (Supporting Information Fig. S1 ), validating our targeted-electroporation approach to manipulate Wnt/bcatenin signaling.
Immunohistochemistry
Pups were injected intraperitoneally with an overdose of pentobarbital (Eutha77 in Ringer's solution), followed by transcardial perfusion of 2.5 ml Ringer's solution and 5 ml 4% paraformaldehyde (PFA) dissolved in phosphate buffered saline (pH 7.4). Brains were dissected and postfixed in PFA for 48 hours at 4 C, then processed for immunohistochemistry, as previously described [9] . Primary antibodies from different species were used, as stated in Supporting Information Table  S2 , followed by species-matched alexa-488, -555, or -647-conjugated secondary antibodies (Life Technologies, Zug, Switzerland, www.lifetechnologies.com), or biotinylated antibodies (Jackson Immunoresearch, Suffolk, United Kingdom, www.jireurope.com) followed by alexa-conjugated Streptavidin for 30 minutes. EdU was given subcutaneously 3 hours before sacrifice to detect cells in active S-phase and previous protocols followed to visualize nucleotide incorporation [9] . Sections were counterstained with DAPI and/or Topro3 (Invitrogen) and coverslipped with antifading mounting medium (Vectashield, Vector Labs, Peterborough, United Kingdom, www.vectorlabs.com) or ProlongGold (Life Technologies, Zug, Switzerland, www.lifetechnologies.com).
Imaging and Quantification Procedures
Imaging and analysis methods are described in detail in our previous methodological study [8] . Electroporation efficiencies vary per animal by 20%, therefore differences in marker expression (Tbr2/Dlx2/Olig2) are indicated as the change in ratios/fate-switch per total number of GFP-expressing cells per series throughout the rostro-caudal axis per animal. For glial fibrillary acidic protein (GFAP)/Mash1/Dcx quantifications, the same procedures were followed by selecting constant fields of view between experimental groups within 70 lm from the boundary of the ventricular surface as described previously [9] . Colocalization was assessed by confocal 3D reconstruction on a Leica SPE II (Leica, Wetzlar, Germany, www.leica.com) or an Olympus FluoView FV1000 (Olympus, Volketswil, Switzerland, www.olympus.ch) confocal microscope equipped with a 340 objective (N.A. 1.25). For densitometric quantification procedures, 70 lm from the ventricular surface in 30 lm stacks with 2 lm intervals of each entire SVZ microdomain was analyzed using standard procedures in ImageJ (National Institute of Health, Bethesda, MD, www. imagej.nih.gov). At least three individual animals, each representing 1 n value, were analyzed for all bGal quantifications. At least five individual animals, each representing 1 n value, were analyzed in all electroporation experiments. For all electroporation experiments, an average of 446.2 transfected cells/animal in serial sections encompassing the entire rostralcaudal axis of the LV was analyzed. At least four individual animals, each representing 1 n value, were analyzed in all pharmacological gain-of-function experiments. Analyses are presented as mean 6 SEM, and samples were compared for significance using unpaired t test (t test) or ANOVA followed by Bonferroni's post hoc test (Prism v3.02; GraphPad, La Jolla, CA, www.graphpad.com).
RESULTS

Wnt/b-Catenin Signaling Is Enriched Within the Dorsal SVZ Microdomain
Gene expression profiles were performed on microdissected dSVZ and lSVZ microdomains, normalizing transcript levels against housekeeping genes by the comparative DD -ct method (Fig. 1A , 1B), as described previously [15] . The results show that transcripts for the early pallial NSC marker, Emx1, the glutamatergic NP transcription factor, Tbr2, and the OP transcription factors, Olig2 and Sox10, were significantly enriched in the dSVZ, while Tbr2 was essentially absent from the lSVZ ( Fig. 1A ; p < .01; t test). By comparison, transcripts for the early subpallial NSC marker Gsx2 and the GABAergic NP transcription factor Dlx2 were highly enriched in the lSVZ, respectively ( Fig. 1A ; p < .05; t test). These results confirm that SVZ microdissection provides a reproducible method for analyzing differences Azim, Fischer, Hurtado-Chong et al. between SVZ microdomains [15] , and support evidence that OPs and glutamatergic interneurons of the olfactory bulb are derived from the dSVZ, whereas the lSVZ has the greatest neurogenic potential for GABAergic interneurons. The Wnt-target genes Fzd1, Axin2, and Lef1 were significantly and specifically enriched in the dSVZ ( Fig. 1B; p < .05, t test) . Notably, the Shhtarget gene Gli1 was enriched in the lSVZ ( Fig. 1B ; p < .05, t test), consistent with its role as a ventralizing factor in the adult SVZ [16] . We also analyzed transcripts for canonical Wnt ligands Wnt3, Wnt3a, Wnt5a, Wnt7a, and Wnt8b in the SVZ and in the choroid plexus, a previously described source of Wnt ligands [27, 28] . In the SVZ, we detected expression only for Wnt3 and Wnt7a. Only Wnt3 showed a dorsal enrichment (Fig. 1C , p < .05, t test) while Wnt7a was homogeneously expressed between the SVZ microdomains (not presented), supporting evidence that Wnt3 is a key factor in the postnatal dSVZ [22] . All tested Wnt transcripts were also detected in the choroid plexus although at different levels (Fig. 1C) , consistent with this tissue being a major source of Wnt ligands in the postnatal brain [27, 29] . The results identify the dSVZ as a previously unrecognized niche for Wnt/b-catenin signaling in the postnatal brain.
Functional Wnt/b-Catenin Signaling Is Localized to the Dorsal SVZ Microdomain
To identify the regional and cellular localisation of canonical Wnt/b-catenin signaling in SVZ microdomains, we used the Bat-Gal reporter transgenic mouse line [23] and infusion of the Wnt mimetic AR-A014418 [18, 21] . In the Bat-Gal mice, bGalactosidase (bGal) expression at P6 was greatest dorsally and declined ventrally ( Fig. 2A) . Throughout the SVZ, bGal1 cells were most dense within the dSVZ, with little expression detected in the lSVZ (Fig. 2B ). Immunostaining demonstrated that the majority of bGal1 cells in the dSVZ were GFAP1 NSCs or coexpressed the proliferative marker Ki67, an indication that they were actively proliferating transient amplifying cells (Fig. 2C ). bGal1 cells also coexpressed the glutamatergic NP marker Tbr2 and the OP marker Olig2 (Fig. 2D) , demonstrating functional Wnt/b-catenin signaling in glutamatergic NPs and OL lineages derived from the dSVZ. Localization of functional Wnt/b-catenin signaling in the SVZ was examined further by infusion of AR-A014418, which inhibits GSK3b to prevent phosphorylation of b-catenin, leading to its nuclear translocation and activation of canonical Wnt/b-catenin targets [18, 21] . Western blot analysis of SVZ microdomains 45 minutes following AR-A014418 infusion demonstrated significant inhibition of GSK3b compared to controls, as determined by phosphorylation of Ser9-GSK3b, and this was significantly greater in the dSVZ compared to the lSVZ ( Fig. 2E, 2F ; p < .05, ANOVA followed by Bonferroni's post hoc test). In agreement, detection of b-catenin in nuclear extracts demonstrated significantly greater Wnt/b-catenin signaling in the 
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dSVZ than in the lSVZ ( Fig. 2E, 2F ; p < .05, ANOVA followed by Bonferroni's post hoc test). In addition, rt-qPCR demonstrated that transcripts for Wnt/b-catenin targets Fzd1, Axin2, Tcf, and Lef1 were all significantly upregulated in the dSVZ 2.5
hours following infusion of AR-A014418, whereas the Shhtarget gene Gli1 was unaltered ( Fig. 2G ; t test, see graph for individual p values) (see list and references in www.stanford. edu/group/nusselab/cgi-bin/wnt/target_genes). Examination of 
Wnt/b-Catenin Signaling Stimulates Proliferation in the Postnatal SVZ
The results presented above demonstrate that infusion of AR-A014418 stimulates Wnt/b-catenin signaling in the dSVZ and so we used this approach to examine the effects of b-catenin signaling on postnatal SVZ-NSCs, as in a previous study in the adult mouse SVZ [18] . Furthermore, we wished to clarify whether Wnt/b-catenin in the postnatal SVZ controls proliferation [18] or differentiation [19] . Pups aged P4 were infused with AR-A014418 or sterile vehicle as controls for 2 days and the SVZ analyzed at P6 by immunostaining for NSCs/cycling cells and rt-qPCR of NSC and SVZ cell markers (Fig. 3) . As described previously [3] , GFAP1 NSCs (type-B) in the postnatal SVZ were identified by their radial glia-like morphology, with cell bodies within the luminal wall of the ventricle and an apical primary process extending into the SVZ (Fig. 3A-3C ). GFAP immunodetection was combined with EdU to further determine their cycling behavior as previous [9] . Mash1 and Dcx immunostaining were used in combination with EdU to identify transiently amplifying cells (type-C, Fig. 3D-3F ) and type-A cells (Supporting Information Fig. S3A-S3C ), respectively. Infusion of AR-A014418 significantly increased GFAP1 NSCs (both total and actively proliferating, i.e. EdU1) by a similar proportion in both dSVZ and lSVZ microdomains ( Fig. 3A-3C ; p < .01, t test). Similarly, the numbers of actively proliferating type-C cells were augmented by a similar proportion in either SVZ region (Fig. 3D-3F ). Finally, Dcx1 neuroblast numbers (type-A cells, Supporting Information Fig. S3A-S3C ; p < .05; t test) increased in both walls, although there were no significant changes in their proliferative behaviors. Overall, the extent of effects of AR-A014418 on proliferation was however higher in the dSVZ than lSVZ, as revealed by densitometry measurements of Proliferating Cell Nuclear Antigen positive (PCNA1) cells (Supporting Information Fig. S3D-S3F ; p < .05, ANOVA followed by Bonferroni's post hoc tests). In addition, we used rt-qPCR of the dSVZ to examine expression of transcripts enriched in type-B, type-C, and type-A cells as well as ependymal and glial cells [30] . Markers for type-B and type-C cells i.e. Dlx4, ABCG2, Nestin, and PCNA were significantly increased in the dSVZ 2.5 hours after AR-A014418 infusion ( Fig. 3G ; p < .05, t test), whereas Dcx was not significantly altered at the mRNA level at this early time point, and neither were markers of other cells that reside in the SVZ (Fig. 3G) . Taken together, these results support the evidence that postnatally, Wnt/b-catenin promotes neurogenesis through increased proliferation of both stem and progenitor cells in either SVZ microdomain.
Wnt/b-Catenin Signaling Regulates Neurogenesis and Oligodendrogenesis in the Postnatal dSVZ Microdomain
We examined the persistent role of Wnt/b-catenin in postnatal dSVZ-NSC specification using both gain-and loss-of-function approaches. Gain-of-function was induced genetically in b-catenin exon3 mice, in which Cre-mediated recombination results in a constitutive stabilized form of b-catenin [24] (Fig. 4) , or by AR-A014418 infusion in wild-type mice (Fig. 5) . Electroporation of GFP plasmid or Cre:GFP plasmid was performed to target specifically defined microdomains of the SVZ, as previously reported [8] . All Cre:GFP transfected cells expressed the Cre recombinase as confirmed by immunostaining (Supporting Information Fig. S4 ). GFP-expressing electroporated cells were identified by immunostaining for lineage-specific markers: Tbr2 for glutamatergic NPs, Dlx2 for GABAergic NPs, and Olig2 for OPs [9, 13] . In targeting the specific microdomains of the SVZ, only NSCs in contact with the ventricular surface incorporate plasmids that are nonintegrating in the genome [8, 31] . The numbers of subsequent progeny expressing GFP 48 hour's post-transfection yield on average 446.2 transfected cells in five serial sections encompassing the entire rostral-caudal axis of the LV (Supporting Information Fig. S1 ). This approach allows a homogeneous sampling of sufficient numbers of fate-mapped NPs as described previously [9] . Following dorsal electroporation of b-catenin exon3 mice (Fig. 4A-4D ), many GFP1 cells could be seen expressing Tbr2 or Olig2 (Fig. 4A, 4C ), whereas fewer expressed Dlx2 (Fig.  4A) . In the dSVZ, b-catenin gain-of-function by Crerecombination in b-catenin exon3 mice resulted in a profound and significant increase in the numbers of Tbr21/GFP1 NPs (Fig.  4A, 4B ) and Olig21/GFP1 OPs (Fig. 4C, 4D ), together with a concomitant and a proportional decrease in Dlx21/GFP1 cells (Fig. 4A, 4B) . Notably, targeted genetic activation of Wnt/b-catenin in the lSVZ of the b-catenin exon3 mouse did not induce Tbr2 or Olig2 expression in GFP1 cells (Fig. 4E-4H) . Similar results were obtained following pharmacological stimulation of b-catenin. Infusion of AR-A014418 promoted the numbers of GFP1/Tbr21 NPs (Fig. 5A-5C ) and GFP1/Olig21 OPs (Fig. 5D-5F ) while decreasing the number of GFP1/Dlx21 NPs. Furthermore, rt-qPCR of the microdissected dSVZ following AR-A014418 infusion demonstrated a specific increase in the dSVZ-NPs and OL lineage transcription factors and markers by more than 2-fold (p < .01, t test), whereas the lSVZ transcription factor Dlx2 was approximately halved (Fig. 5G) . Interestingly, the early dSVZ marker Emx1 was unaffected, indicating Wnt/b-catenin signaling acts downstream of this transcription factor.
The genetic and AR-A014418 gain-of-function data showed that Wnt/b-catenin stimulates differentiation of dSVZ-NSCs along a glutamatergic NP and OP fate. This was examined further by genetic loss-of-function in b-catenin lox/lox and b-catenin dm/lox mice, the former to assess ablation of the entire b-catenin coding sequence [25] , and the latter to assess exclusive ablation of canonical Wnt pathway activity, but retaining the cell adhesion function of b-catenin [26] . Targeted Cre-recombination in dSVZNSCs had equivalent effects in both transgenic mice, resulting in significant decreases in Tbr21/GFP1 NPs and increases in Dlx21/GFP1 NPs ( Fig. 6A-6C ; see graphs for p values). These gain-and loss-of-function findings demonstrate a novel functional role for the signaling form of b-catenin in dorsalization of the SVZ and indicate that it is necessary and sufficient for specification of NSCs toward the glutamatergic NP lineage. Interestingly, b-catenin loss-of-function did not alter the proportions of Olig21/GFP1 OPs (Fig. 6D-6F) , contrasting with the effects of b-catenin gain-of-function (Figs. 4C, 4D , 5D-F), and indicating that Wnt/b-catenin acts in concert with other signaling pathways to regulate oligodendrogliogenesis in the dSVZ.
DISCUSSION
The function of Wnt/b-catenin signaling on the genesis of specific neuronal lineages from spatially segregated dorsoAzim, Fischer, Hurtado-Chong et al. Our expression profiling of the microdissected SVZ shows that spatially restricted populations of NSCs persist in the SVZ after birth and express lineage-specific transcription factors that determine their neurogenic fate. These results together with previous fate mapping studies demonstrate that Olig21 OPs and Tbr21 olfactory glutamatergic NPs derive from the dSVZ microdomain, whereas Dlx21 GABAergic NPs derive from both the dSVZ and lSVZ [7, [12] [13] [14] [15] . The heterogeneity of SVZ-NSCs was originally thought to be intrinsically coded [7] , but our expression profiling in microdissected SVZ identifies canonical Wnts as the key dorsalizing factor in the postnatal SVZ, opposing ventrally localized Shh activity to determine dorso-ventral NSC fate [16, 17, 32] . Functional b-catenin expression was examined by immunodetection of bGal in Wnt-signaling reporter mice [23] . Wnt/bcatenin activity was highest in GFAP1 NSCs and actively proliferating transiently amplifying (type-C) cells of the dSVZ, supporting observations in the embryonic and adult brain [18, 33] . In addition, using infusion of the GSK3b inhibitor AR-A014418 to inhibit phosphorylation of b-catenin and stimulate its nuclear translocation, we demonstrate that endogenous b-catenin is highly localized to the dSVZ, and results in activation of canonical Wnt/b-catenin targets Tcf and Lef1 as well as Fzd1 and Axin2. Activation of b-catenin activity stimulated proliferation most dramatically in the dSVZ microdomain, consistent with other studies using in vitro and in vivo approaches [18, 22] . A new finding is that the highest functional Wnt/b-catenin activity defines the dSVZ-NSCs and their progeny, Tbr21 NPs and Olig21 OPs. Furthermore, AR-A014418 did not affect expression of Gli1, a downstream target of Shh signaling in dSVZ-NSCs [32] , which maintains ventralization of the postnatal SVZ [34] , providing further evidence that Wnt/b-catenin signaling exerts a direct dorsalizing effect on the postnatal SVZ.
We could confirm an augmentation of NSCs and progenitor cell number and proliferation in the lSVZ following AR-A014418 infusion. A similar increase has been previously described at E13.5 following ablation of GSK3b in NSCs [35] as well as in the adult mouse using other GSK3b inhibitors [18] . In this study, these effects are unlikely to involve activation of the canonical Wnt pathway as no induction of downstream Wnt/b-catenin-target genes was detected in the lSVZ following AR-A014418 infusion. The effects of GSK3b inhibition in promoting neurogenesis from the lSVZ involve other signaling pathways. In addition to the increase proliferation which was more pronounced in the dSVZ, our b-catenin gain-and loss-of-function studies underline that Wnt/b-catenin regulates fate specification of dSVZNSCs. Analysis of NSC progeny following genetic or pharmacological stimulation of b-catenin demonstrated more Tbr21 NPs at the expense of Dlx21 NPs. Consistently, targeted genetic ablation of b-catenin activity in dSVZ-NSC had the opposite effect, resulting in a marked decrease in Tbr21 NPs and a proportional increase in Dlx21 NPs. It is noteworthy that targeted genetic stimulation of b-catenin activity in NSCs of the lSVZ failed to induce Tbr2 expression. This nonpermissiveness of lSVZ-NSC appears to be a postnatal acquisition, since embryonic respecification of ventral NSCs can be achieved by expression of constitutively active b-catenin, resulting in partial expression of dorsally restricted markers in the ventral forebrain (most notably Ngn2) and a decrease in expression of ventral-restricted markers [17] .
An important finding is that Wnt/b-catenin is a profound positive regulator of oligodendrogliogenesis from dSVZ-NSCs. Notably, our studies indicate OL lineage cells are largely derived from the dSVZ microdomain, together with glutamatergic NPs. Moreover, we failed to induce ectopic generation of OPs in the lSVZ following genetic or pharmacological stimulation of b-catenin activity. This contrasts with the effects of FGF2, which we have shown to promote ectopic generation of OPs from the lSVZ [15] . In confirmation of our fatemapping results, transcripts for more differentiated OL lineage cells, PDGFaR and PLP, were markedly increased by AR-A014418, consistent with our previous study showing that AR-A014418 promotes differentiation as well as proliferation of OL lineage cells [21] . Our findings are in line with a recent parallel study showing that in vivo activation of canonical Wnt signaling increased the generation of Olig21 and PDGFaR1 OPs in the adult SVZ [22] , but do not support the conclusion that Wnt/b-catenin is selective for OL lineage cells. Indeed, as discussed above, our studies clearly demonstrates that Wnt/bcatenin also promotes neurogenesis and regulates NP fate along the glutamatergic versus the GABAergic lineage. Interestingly, oligodendrogliogenesis was promoted by stimulation of b-catenin signaling, but was unaffected by genetic inhibition of b-catenin, in contrast to neurogenesis, which was affected by both b-catenin gain-and loss-of-function. These results suggest Wnt/b-catenin is necessary and sufficient for specification of NSCs along the glutamatergic NP lineage, but acts in concert with other factors to regulate oligodendrogliogenesis [15, 21] .
CONCLUSION
In conclusion, this study highlights a novel role for Wnt/bcatenin signaling in promoting glutamatergic neurogenesis and oligodendrogliogenesis from the dorsal microdomain of the postnatal SVZ.
